Evaluation of AP-002 in Patients With Solid Tumors
Clinical trial NCT04143789 · UNKNOWN
Trial details
- NCT number
- NCT04143789
- Sponsor
- Altum Pharmaceuticals INC
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-27
- Primary completion
- 2021-03-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.